Atlas Trials

Gut Microbiota Reconstruction for NSCLC Immunotherapy

Clinical trial NCT05008861 · UNKNOWN

Trial details

NCT number
NCT05008861
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2021-09-01
Primary completion
2022-12-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.